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Abstract 
Recombinant erabutoxin a (Ea ) has been crystallized by vapour diffusion in hanging drops. The crystals belong to space group P2,2i2, with cell 
dimensions a = 55.8 A. b = 53.4 A. c = 40.8 A. Diffraction data have been recorded on a FAST detector un to 2.0 A. The atomic crystal structure 
of Ea, has been determined by initial refinement of the structure of the isotoxin erabutoxin b (Eb) the cry&Is of which were grown under identical 
conditions. The R-factor was 23% at 2.0 A resolution. The secondary and tertiary structures of Ea, are shown to be identical with that of wild-type 
Eb, within the experimental error. 
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1. In~~u~tion 
Curaremimetic toxins are small proteins found in ven- 
oms from snakes classified as Elapidae and Hydro- 
phiidae [ 11. They block nicotinic acetylcholine receptors 
from various snake prey with great specificity and high 
affinity. Their equilibria dissociation constants fre- 
quently range between 1 and 20 ’ lt3” M. With the view 
to delineate the site by which these toxins recognize their 
target, the cDNA encoding erabutoxin a (Ea), a curar- 
emimetic toxin from the venom of the sea-snake, Lati- 
cat& semz~asc~atff, was previously cloned [2], expressed 
as a hybrid protein fused to protein A from ~tffp~ylucoc- 
cus aureus [3], and the recombinant oxin (Eq) generated 
in vitro by treating the hybrid in acidic conditions with 
cyanogen bromide [4]. Despite this drastic treatment, Ea, 
had identical toxicity in mice, similar affinity for Ac- 
ChoR from Torpedo rnffrrnor~tff and su~~mposable cir- 
cular dichroism spectra as compared to Ea from snake 
venom [4]. However, the 3D-structure of Ea, remained 
to be elucidated. 
Three erabutoxins, a, b and c, are present in the venom 
of L. semifasciata [IO]. They all possess 62 amino acids, 
including four half-cystines, and differ from each other 
by a single amino acid at position 26 or 51. The crystal 
*Corresponding author. Fax: (33) (1) 69 08 90 71. 
Abbreviations: Ea, Erabutoxin a; Ea,, recombinant erabutoxin; Eb, 
erabutoxin b, AcChoR, acetylcholine receptor. 
structures of these toxins were previously elucidated at 
different resolutions, starting from crystals grown under 
various experimental conditions [5,11,12]. All toxins dis- 
play highly similar polypeptide foldings composed of 
three adjacent loops rich in p-pleated sheets which 
emerge from a small globular core where the four 
disulphides are localized. We therefore investigated 
whether or not Ea, adopts the same folding. 
Crystals of Ea, have been obtained using KSCN as a 
crystallizing agent, according to the procedure already 
described to crystallize erabutoxin b (Eb) [S]. These crys- 
tallization conditions lead to a dimeric form, which was 
originally reported by Preston et al., for EC and Eb [6]. 
X-ray diffraction data were recorded and the 3D struc- 
ture of Ea, was solved at 2.0 A resolution starting from 
the 3D structure of Eb crystallized under the same condi- 
tions [5]. In this paper the 3D structure of Ea, is com- 
pared with that of wild-type erabutoxins and especially 
with that of Eb. 
2. Experimental 
2.1. Production and purl~catio~ of Ea, 
A recombinant expression plasmid encoding a protein A-Ea, fusion 
protein was constructed as described by Ducancei et al. 131. The fused 
toxin was expressed in the periplasmic space of E. coli and purified by 
a single immuno-affinity step using an IgG Sepharose 6FF (Pharmacia) 
column. The fused toxin was separated from protein A on a C4 column 
(Vydac 5,~. 25 x 10 mm) with a trifluoroacetic acid/acetonitrile system. 
Appropriate mutation in the plasmid had introduced a methionine at 
position -1 of the Ea, sequence and a treatment of the hybrid with 
0014-5793/94/$7.00 0 1994 Federation of European Biochemical Societies. All rights reserved. 
SSDI 0014-5793(94)00204-9 
B. Arnoux et al.lFEBS Letters 342 (1994) 12-14 13 
cyanogen bromide released the unfused Ea, moiety [4]. The CNBr- 
treated hybrid was submitted to reverse-phase high pressure liquid 
chromatography, using a C4 column (Vydac 5~, 25 x 10 mm) equili- 
brated with TEAF and eluted with a gradient of acetonitrile. The 
resulting Ea, was further chromatographed on a mono S HR5/5 (Phar- 
macia) column using an ammonium acetate gradient. Ea, was judged 
to be homogeneous from both SDS-PAGE and isoelectrofocusing. The 
amino acid composition of Ea, was identical to that of Ea from venom. 
2.2. Crystallization 
Ea, and Ea were crystallized using the procedure described by Sa- 
ludjian et al. [5] to crystallize Eb isolated from snake venom [7]. Crystals 
of Ea, and Ea were grown at 18°C by vapour diffusion in Linbro tissue 
culture plates. Four 10 ~1 hanging drops of a solution of sodium acetate 
buffer (50 mM, pH 4.5) containing the toxin (2.5 mM) and KSCN 
(145-160 mM) as crystallizing agent were equilibrated against 290-320 
mM KSCN reservoirs, at the same pH. Crystals of Ea, and Ea grow 
like prisms in all drops within a few days. They belong to the space 
group, P2,2,2,, with 2 molecules in the asymmetric unit. Using experi- 
mental conditions identical to those described above, we found the 
same crystal form for Ea and Eb [5]. This crystal form was originally 
described by Preston et al. [6] for the wild-types Ec and Eb. The unit 
cell parameters of erabutoxins crystallized with SCN- are indicated in 
Table 1. 
2.3. Data collection and processing 
Data from one single crystal 0.1 x 0.1 x 0.05 mm in size were col- 
lected to 2.0 A reolution on a FAST detector, using a Nonius generator 
(rotating anode) and Cu KCY radiation selected with a graphite mono- 
chromator. The swing angle of the detector was 25”. Data were col- 
lected by steps of 0.15”, over 150 s. MADNES software was used to 
process all the data. After averaging intensities of 12,030 reflections 
(R,, = 8.9% at 2 A resolution), a total of 7,708 independent intensities 
were obtained. 
The structure was refined by starting from the Eb three-dimensional 
structure [5] (6EBX protein Data Bank [S]). The two independent mol- 
ecules of the asymmetric unit were refined using the XPLOR molecular 
dynamics program [9]. After several cycles of crystallographic d namic 
refinement, with a step-by-step increasing resolution from 3.0 Kto 2.0 
A, a slow-cooling annealing procedure was applied (from 4,000 to 300 
K). The R-value was reduced to 23% (7,053 Fobs > 2 a). Only minor 
manual adjustments were required for a few side chains. In addition, 
Pro-48 in both molecules of the asymmetric unit appeared highly disor- 
dered, and Gly-20 and Gly-34 in one of the two molecules were poorly 
defined. The model presently refined includes 1,057 protein atoms, 50 
water molecules and one SCN- ion per asymmetric unit. The thermal 
factors of water molecules were limited to 60 A’. The overall rms 
deviations are 0.007 A and 1.6” on distances and angles, respectively. 
Table 1 
Crystal parameters of erabutoxins 
Ea, 
Ea 
Eb 
a (4 b (A) c (4 Ref. 
55.8 f 0.1 53.4 f 0.1 40.8 It 0.1 This work 
55.9 f 0.1 53.3 f 0.1 40.7 f 0.1 This work 
55.7 f 0.1 53.3 Z!Z 0.1 40.9 f 0.1 [5] 
3. Results and discussion 
As shown in Table 1, the crystal parameters of Ea, are 
identical to those of Ea and Eb, grown under identical 
conditions in the presence of KSCN. As described by 
Saludjian et al. [5], the recombinant oxin crystallized in 
a dimeric form. In addition, a preliminary crystal struc- 
ture of Ea, (not shown) was similar to those previously 
reported for the erabutoxins a, b or c isolated from snake 
venom [5,11,12]. In particular, each molecule of the 
dimer had five antiparallel B-sheet strands encompassing 
residues 2-5, 13-17, 24-32, 34-41 and 51-56. Five /?- 
bends were found between residues 7-10 (type II), 18-2 1 
(type II), 31-34 (type I), 47-50 (type II) and 57-60 (type 
II). The turns 18-21 and 47-50 were close to ideal. Not 
only did Ea, and venom erabutoxins have similar second- 
ary structures, but there was excellent agreement regard- 
ing their overall three-dimensional architectures. In 
particular, each molecule had a leaf-shaped structure 
organized in three adjacent loops emerging from a small 
globular core. The C-terminal part of the polypeptide 
chain interacted with residues on the convex side of the 
toxin. A concave face was predominantly found within 
the central and third loops. 
To get a better insight into the similarity of the crystal 
structures of recombinant and wild-type erabutoxins, we 
solved the structure of Ea, at 2.0 A and superimposed its 
backbone with that of Eb [5]. The reason why we selected 
Fig. 1. Superimposition of the backbones of recombinant Ea (-) and wild-type Eb (...). Eb data are from [5] with permission. 
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Fig. 2. Averaged thermal factors of main chain atoms of Ear (-) and 
Eb (- -) of the two molecules, A and B, in the asymmetric unit, vs. 
amino acid sequences. 
the Eb structure for the comparison is twofold. First, the 
~r~-dimensional crystal structures of Ea and Eb, two 
isoforms that differ from each other by a single substitu- 
tion at position 26, are highly similar to each other 
[11,12]. Second, the three-dimensional structure of Eb 
was recently solved from crystals grown under condi- 
tions [5] that are identical to those that have been used 
to produce the Ea, crystals. As shown in Fig. 1, the 
foldings of Ea, and Eb polypeptide chains virtually coin- 
cide. The average rms deviation between all a-carbons 
is 0.21 A. Furthermore, for both structures, the highest 
B-values are identified in similar regions (Fig. 2) and 
there is a good fit between the four disulphides of Ea, and 
Eb. 
In conclusion, the present work demonstrates that the 
overall crystal structure of recombinant Ea is identical, 
within the experimental error, to that of Eb determined 
in the same crystal form [S]. We therefore infer that the 
3D structure of the Ea, backbone is also identical to that 
of Ea from snake venom. This conclusion is of particular 
interest for several reasons. First, it fully agrees with our 
previous findings indicating that the secondary structure 
of Ea, and Ea are identical, as judged from circular 
dichroism spectra [4]. Second, Ea, was synthesized as a 
fusion protein in the periplasmic space of E. coli [3] and 
its disulphides have not been sub~tted to any reduction/ 
reoxidation step. The present data reveal that the di- 
sulphides that were formed during the biosynthesis in E. 
coli are paired as they are in the toxin produced in the 
venom gland of the snake. Third, the data indicate that 
the drastic treatment o which Ea, was submitted during 
its isolation, in particular the cleavage step by CNBr 
which was carried out under acidic conditions, did not 
alter the structural properties of the toxin. Finally, Ea, 
can now be confidently used to explore the mutation- 
based effects on the curaremimetic function of Ea, as 
recently described by Pillet et al. [3]. 
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